Zhongnan Mountain 5g connected Shenzhen consultation


Zhongnan Mountain 5g connected Shenzhen consultation

Shenzhen Special Zone News Guangzhou (Reporter Liu Lianglong) November 17th, Academician, Chinese Academy of Engineering, Director of the National Respiratory Disease Clinical Medicine Research Center of the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Respiratory Health Research Institute leader Zhongnan Mountain passed 5G Line, the joint team experts have conducted an academician investment in the Shenzhen Respiratory Disease Research Institute.

This is a multidisciplinary consultation for the first time by 5G connection methods since July this year. This connection is provided by Guangzhou Respiratory School, Shenzhen Respiratory Disease Research Institute, and the multi-disciplines experts have discussed and designated the next treatment plan.

11 days ago, the 57-year-old Zhu is admitted to the hospital for repeated coughs. She told Zhong Nanshan Academician, before I saw it in other hospitals, inform her "Your lungs are rotten, the situation is very urgent, hurry to stay," she will believe in suspicion, and finally choose to stay in the Shenzhen People’s Hospital.

After admission, after laboratory examination, most indicators showed normal, preliminary diagnosis results were abnormal immune indexes with chronic mesenchymal pulmonary disease with serological immune indicators. But Ms. Zhu has no history of smoking, and there is no history of new crown epidemiology, what is the cause of interstitial pneumonia? The clinical manifestations seem to be slight, but the chest CT has obvious abnormalities, and the lung function has also begun, which may be caused by mesenger pneumonia? What is the next treatment direction? The opinions of the Shenzhen Respiratory Disease Research Institute are also inconsistent. The multidisciplinary discussion is discussed after the end of the epidemic, and the diagnosis and treatment of Ms. Zhu is thrown out by one: "The classification and cause of intersive lung disease?" Program: follow-up observation? Anti-inflammatory treatment? Or anti-fibrosis treatment? "Hosted by Zhongnan Mountain, the respiratory medicine, rheumatism, blood internal medicine, infected internal medicine, imaging department, pathology department, etc. The team experts discuss case diagnosis and treatment programs, and give a consistent opinion: patients are currently in the development stage of connective tissue diseases, and her lungs are also caused by, although the activity is still, but chest CT The performance cannot be ignored, and there has been a decline in lung function. In order to improve the lung function and future quality of life, it is necessary to start anti-fibrotic treatment, and control the treatment of connective tissue disease, and continue to follow up in the future, if the condition has different directions Development may also need to use anti-inflammatory drugs. Zhong Nanshan academician expressed its affirmation on the Shenzhen People’s Hospital in the form of 5G connection room, and encouraged the hospital to vigorously develop these high-tech assistance methods.

立 立 立: 刘良龙.